GEN Exclusives

More »

GEN News Highlights

More »
May 15, 2007

Jacobs to Provide Services to Biogen Idec for Biotechnology Project in Denmark

  • Jacobs Engineering Group won a contract from Biogen Idec to provide engineering, procurement, validation, and site support services for the first cell culture manufacturing facility at the greenfield biotechnology plant in Hillerod, Denmark.

    This plant is expected to produce TYSABRI® (natalizumab), which is used in the treatment of multiple sclerosis. The companies expect the facility to be completed in 2009.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?